Neuroprotection in multiple sclerosis: a therapeutic approach.
about
A randomized controlled phase II trial of riluzole in early multiple sclerosis.Visual pathway neurodegeneration winged by mitochondrial dysfunction.Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis.Retinal axonal loss in very early stages of multiple sclerosis.
P2860
Neuroprotection in multiple sclerosis: a therapeutic approach.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neuroprotection in multiple sclerosis: a therapeutic approach.
@en
type
label
Neuroprotection in multiple sclerosis: a therapeutic approach.
@en
prefLabel
Neuroprotection in multiple sclerosis: a therapeutic approach.
@en
P2860
P1433
P1476
Neuroprotection in multiple sclerosis: a therapeutic approach.
@en
P2093
Alireza Minagar
Amir-Hadi Maghzi
P2860
P2888
P304
P356
10.1007/S40263-013-0093-7
P577
2013-10-01T00:00:00Z